v3.25.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock  
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
(Accumulated Deficit) Retained Earnings
Common shares outstanding, beginning balance (in shares) at Dec. 31, 2022   1,275,128,567      
Balance, beginning of the year at Dec. 31, 2022 $ 8,239 $ 8,747 $ 30 $ (16) $ (522)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   3,915,216      
Exercise of stock options 60 $ 109 (49)    
Stock-based compensation 615   615    
Vesting of restricted share units (in shares)   7,288,043      
Vesting of restricted share units 0 $ 335 (335)    
Issuance of shares related to business acquisitions (in shares)   238,468      
Issuance of shares related to business acquisitions 0 $ 10 (10)    
Net income and comprehensive income (loss) for the year 152     20 132
Common shares outstanding, ending balance (in shares) at Dec. 31, 2023   1,286,570,294      
Balance, end of the year at Dec. 31, 2023 $ 9,066 $ 9,201 251 4 (390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 2,576,628 2,576,628      
Exercise of stock options $ 61 $ 89 (28)    
Stock-based compensation 430   430    
Vesting of restricted share units (in shares)   5,433,218      
Vesting of restricted share units (4) $ 344 (348)    
Net income and comprehensive income (loss) for the year 2,005     (14) 2,019
Common shares outstanding, ending balance (in shares) at Dec. 31, 2024   1,294,580,140      
Balance, end of the year at Dec. 31, 2024 $ 11,558 $ 9,634 305 (10) 1,629
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 4,739,441 4,739,441      
Exercise of stock options $ 232 $ 342 (110)    
Stock-based compensation 449   449    
Vesting of restricted share units (in shares)   4,332,463      
Vesting of restricted share units (8) $ 376 (384)    
Issuance of shares related to business acquisitions (in shares)   252,257      
Issuance of shares related to business acquisitions 0 $ 24 (24)    
Net income and comprehensive income (loss) for the year 1,242     11 1,231
Common shares outstanding, ending balance (in shares) at Dec. 31, 2025   1,303,904,301      
Balance, end of the year at Dec. 31, 2025 $ 13,473 $ 10,376 $ 236 $ 1 $ 2,860